Aurobindo gets FDA green light for generic Tobi

Aurobindo has received the Food and Drug Administration’s blessing for tobramycin inhalation solution, 300 mg/5 mL.

The product is indicated for cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa.

It is the generic of Novartis’ Tobi Inhalation Solution.